Navigation Links
What is the clinical features of primary aortoenteric fistula?
Date:9/24/2008

PAEF is a rare but often life-threatening cause of massive gastrointestinal bleeding. PAEFs have a mortality rate of nearly 100% in the absence of surgical intervention, and in most case, the diagnosis is not established preoperatively. This report presents one such case wherein the cause of death was PAEF-induced massive gastrointestinal bleeding that occurred after discharge of the patient from the hospital. Few previous reports on PAEF provide both the clinical course, including gastrointestinal endoscopic findings, and detailed autopsy findings.

A research team was led by Dr. Ihama address this case and was published on August 7, 2008 in the World Journal of Gastroenterology.

They found that a considerable number of sudden and unexpected deaths have occurred due to PAEFs in cases wherein the diagnosis had not been established. The incidence of PAEF is probably higher than estimated. Moreover, PAEF is a fatal but not an untreatable gastrointestinal disease. However, a PAEF patient cannot be saved without early diagnosis because only an appropriate and urgent surgical invention can rescue the patient. The classical triad of symptoms, i.e., gastrointestinal bleeding, abdominal pain, and a pulsating abdominal mass is probably overemphasized because it occurs in less than 25% of PAEF cases. On the contrary, PAEFs usually present with a herald bleed prior to exsanguination, which is usually minor and self-limiting. If PAEF is diagnosed simultaneously with the herald bleeding, surgical therapy may salvage many patients of PAEF.

Endoscopy is generally the most preferred primary procedure and provides valuable information in cases of gastrointestinal bleeding. In PAEF patients, absence of identifiable bleeding lesions on initial gastrointestinal endoscopy is regarded by clinicians as a strong indicator for laparotomy. However, gastrointestinal endoscopy may be a double-edged sword when PAEFs coexist with multiple bleeding sites. Furthermore, even detection of coexisting bleeding sites by upper endoscopy or colonoscopy, even by capsule endoscopy, may be misleading. Ultimately, the key to early diagnosis of PAEF is endoscopist's heightened index of suspicion; therefore, endoscopists need to recognize PAEF as a potential cause of gastrointestinal bleeding. This article is a valuable step to publicize PAEF.


'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Related medicine news :

1. Medicare HMO costs may prevent cancer patient clinical trial participation
2. DIA Conference to Present Latest Strategies in Clinical Trial Disclosure Compliance
3. Novel tuberculosis vaccine in Germany in clinical phase
4. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
5. Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development
6. VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients
7. Shaping Best Practices For Standardized Medical Imaging In Clinical Trials
8. New probe to detect skin cancer receives more funding for clinical trials
9. Prototype test for predicting clinical outcome for melanoma patients
10. Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads
11. Clinical Research Management gets contract for trials of therapeutics against infectious diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... PurhealthRX , a leading Health and Nutrition Company, ... Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market by ... be easily incorporated into liquid products, while reducing costs to end users. , The ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: